(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.
The three most active and biggest winners today are Li Auto, Viking Therapeutics, and MicroVision.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | Li Auto (LI) | 23.66 | 7.45% | 2022-05-17 07:19:08 |
| 2 | Viking Therapeutics (VKTX) | 2.49 | 6.41% | 2022-05-17 07:20:51 |
| 3 | MicroVision (MVIS) | 3.28 | 6.15% | 2022-05-17 07:32:43 |
| 4 | DouYu (DOYU) | 1.56 | 5.41% | 2022-05-17 07:18:32 |
| 5 | Xylem (XYL) | 85.89 | 5% | 2022-05-17 07:31:14 |
| 6 | Xenetic Biosciences (XBIO) | 0.75 | 5% | 2022-05-17 07:20:54 |
| 7 | Amicus Therapeutics (FOLD) | 7.81 | 4.41% | 2022-05-17 04:16:45 |
| 8 | Match Group (MTCH) | 79.00 | 4.29% | 2022-05-17 07:19:22 |
| 9 | Trip.com (TCOM) | 21.86 | 4.19% | 2022-05-17 07:20:17 |
| 10 | NortonLifeLock (NLOK) | 24.89 | 4.01% | 2022-05-17 07:19:30 |
The three most active and biggest losers today are HDFC Bank Limited, Mizuho Financial Group, and TJX Companies.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | HDFC Bank Limited (HDB) | 51.35 | -3.11% | 2022-05-17 06:41:03 |
| 2 | Mizuho Financial Group (MFG) | 2.27 | -0.87% | 2022-05-17 05:47:58 |
| 3 | TJX Companies (TJX) | 56.00 | -0.21% | 2022-05-17 07:30:26 |
| 4 | America Movil (AMOV) | 19.27 | -0.1% | 2022-05-17 04:06:15 |
| 5 | Mid (MAA) | 177.09 | -0.08% | 2022-05-17 04:43:11 |
| 6 | Genworth Financial (GNW) | 3.94 | 0% | 2022-05-17 07:00:51 |
| 7 | Fox Corporation (FOX) | 31.11 | 0% | 2022-05-17 04:16:48 |
| 8 | Identiv (INVE) | 11.52 | 0% | 2022-05-17 04:18:03 |
| 9 | Arcturus Therapeutics (ARCT) | 16.84 | 0% | 2022-05-17 07:17:43 |
| 10 | Vanguard Short-Term (VGSH) | 59.16 | 0.02% | 2022-05-17 07:22:51 |
Most Active Premarket Winners today
1. Li Auto (LI) – Premarket: 7.45%
NASDAQ ended the session with Li Auto rising 0.92% to $22.02 on Tuesday, after five consecutive sessions in a row of gains. NASDAQ fell 1.2% to $11,662.79, following the last session’s downward trend on what was an all-around bearish trend trading session today.
Volume
Today’s last reported volume for Li Auto is 5874990, 44.01% below its average volume of 10494000.
Li Auto’s last close was $22.02, 41.2% below its 52-week high of $37.45.
Li Auto’s Sales
Li Auto’s sales growth is 123.1% for the ongoing quarter and 154.3% for the next. The company’s growth estimates for the present quarter is a negative 50% and positive 16.7% for the next.
Li Auto’s Revenue
Year-on-year quarterly revenue growth grew by 209.7%, now sitting on 20.54B for the twelve trailing months.
Volatility
Li Auto’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.09%, a negative 0.62%, and a positive 5.09%, respectively.
Li Auto’s highest amplitude of average volatility was 3.12% (last week), 3.72% (last month), and 5.09% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Li Auto’s stock is considered to be oversold (<=20).
Li Auto’s Stock Yearly Top and Bottom Value
Li Auto’s stock is valued at $22.02 at 08:34 EST, way below its 52-week high of $37.45 and way above its 52-week low of $16.86.
Li Auto’s Moving Average
Li Auto’s value is under its 50-day moving average of $24.38 and way under its 200-day moving average of $28.44.
More news about Li Auto.
2. Viking Therapeutics (VKTX) – Premarket: 6.41%
NASDAQ ended the session with Viking Therapeutics jumping 0.21% to $2.34 on Tuesday, after five consecutive sessions in a row of gains. NASDAQ dropped 1.2% to $11,662.79, following the last session’s downward trend on what was an all-around bearish trend trading session today.
Volume
Today’s last reported volume for Viking Therapeutics is 726148, 25.53% below its average volume of 975170.
Viking Therapeutics’s last close was $2.34, 76.81% below its 52-week high of $10.09.
The company’s growth estimates for the ongoing quarter and the next is a negative 61.5% and a negative 46.7%, respectively.
Volatility
Viking Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.60%, a negative 0.84%, and a positive 3.41%, respectively.
Viking Therapeutics’s highest amplitude of average volatility was 4.62% (last week), 4.44% (last month), and 3.41% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Viking Therapeutics’s stock is considered to be oversold (<=20).
Viking Therapeutics’s Stock Yearly Top and Bottom Value
Viking Therapeutics’s stock is valued at $2.34 at 08:34 EST, way below its 52-week low of $4.81.
Viking Therapeutics’s Moving Average
Viking Therapeutics’s worth is way below its 50-day moving average of $5.82 and way below its 200-day moving average of $6.03.
More news about Viking Therapeutics.
3. MicroVision (MVIS) – Premarket: 6.15%
NASDAQ ended the session with MicroVision falling 4.33% to $3.09 on Tuesday while NASDAQ fell 1.2% to $11,662.79.
Volume
Today’s last reported volume for MicroVision is 1903590, 56.8% below its average volume of 4407130.
MicroVision’s last close was $3.09, 87.48% under its 52-week high of $24.69.
MicroVision’s Sales
MicroVision’s sales growth is 39.2% for the present quarter and 56.6% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 250% and a negative 125%, respectively.
MicroVision’s Revenue
Year-on-year quarterly revenue growth grew by 12.4%, now sitting on 2.34M for the twelve trailing months.
Volatility
MicroVision’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.45%, a negative 0.91%, and a positive 6.77%, respectively.
MicroVision’s highest amplitude of average volatility was 10.02% (last week), 6.23% (last month), and 6.77% (last quarter), respectively.
MicroVision’s Stock Yearly Top and Bottom Value
MicroVision’s stock is valued at $3.09 at 08:34 EST, way below its 52-week high of $24.69 and way above its 52-week low of $2.50.
MicroVision’s Moving Average
MicroVision’s value is way below its 50-day moving average of $3.87 and way below its 200-day moving average of $7.28.
More news about MicroVision.
4. DouYu (DOYU) – Premarket: 5.41%
NASDAQ ended the session with DouYu rising 0.34% to $1.48 on Tuesday, after five consecutive sessions in a row of gains. NASDAQ slid 1.2% to $11,662.79, following the last session’s downward trend on what was an all-around down trend exchanging session today.
Volume
Today’s last reported volume for DouYu is 721117, 66.45% below its average volume of 2149430.
DouYu’s last close was $1.48, 83.37% under its 52-week high of $8.90.
The company’s growth estimates for the present quarter and the next is 28.6% and 50%, respectively.
DouYu’s Revenue
Year-on-year quarterly revenue growth declined by 7.8%, now sitting on 9.11B for the twelve trailing months.
Volatility
DouYu’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.73%, a negative 1.58%, and a positive 6.60%, respectively.
DouYu’s highest amplitude of average volatility was 6.04% (last week), 5.25% (last month), and 6.60% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
DouYu’s stock is considered to be oversold (<=20).
DouYu’s Stock Yearly Top and Bottom Value
DouYu’s stock is valued at $1.48 at 08:34 EST, way under its 52-week high of $8.90 and way higher than its 52-week low of $1.24.
DouYu’s Moving Average
DouYu’s value is way below its 50-day moving average of $1.87 and way below its 200-day moving average of $2.73.
More news about DouYu.
5. Xylem (XYL) – Premarket: 5%
NYSE ended the session with Xylem sliding 2.51% to $81.80 on Tuesday, after four consecutive sessions in a row of losses. NYSE jumped 0.02% to $15,259.82, after three consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.
Volume
Today’s last reported volume for Xylem is 794832, 43.58% below its average volume of 1408830.
Xylem’s last close was $81.80, 41.06% under its 52-week high of $138.78.
Xylem’s Sales
Xylem’s sales growth is 8.1% for the ongoing quarter and 5.9% for the next. The company’s growth estimates for the current quarter and the next is 3.2% and 2.5%, respectively.
Xylem’s Revenue
Year-on-year quarterly revenue growth grew by 3.7%, now sitting on 5.25B for the twelve trailing months.
Volatility
Xylem’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.52%, a negative 0.05%, and a positive 1.75%, respectively.
Xylem’s highest amplitude of average volatility was 1.95% (last week), 2.42% (last month), and 1.75% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Xylem’s stock is considered to be oversold (<=20).
Xylem’s Stock Yearly Top and Bottom Value
Xylem’s stock is valued at $81.80 at 08:34 EST, way under its 52-week low of $94.63.
Xylem’s Moving Average
Xylem’s value is way below its 50-day moving average of $125.77 and way below its 200-day moving average of $120.36.
More news about Xylem.
6. Xenetic Biosciences (XBIO) – Premarket: 5%
NASDAQ ended the session with Xenetic Biosciences rising 8.48% to $0.71 on Tuesday, after five sequential sessions in a row of gains. NASDAQ fell 1.2% to $11,662.79, following the last session’s downward trend on what was an all-around negative trend exchanging session today.
Volume
Today’s last reported volume for Xenetic Biosciences is 87813, 58.57% below its average volume of 211976.
Xenetic Biosciences’s last close was $0.71, 87.5% below its 52-week high of $5.68.
Xenetic Biosciences’s Sales
Xenetic Biosciences’s sales growth is 72.4% for the present quarter and a decline by 33.8% for the next. The company’s growth estimates for the current quarter and the next is 90% and 6.3%, respectively.
Xenetic Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.
Volatility
Xenetic Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.56%, a negative 2.60%, and a positive 3.72%, respectively.
Xenetic Biosciences’s highest amplitude of average volatility was 6.31% (last week), 4.74% (last month), and 3.72% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Xenetic Biosciences’s stock is considered to be oversold (<=20).
Xenetic Biosciences’s Stock Yearly Top and Bottom Value
Xenetic Biosciences’s stock is valued at $0.71 at 08:34 EST, way under its 52-week low of $1.21.
Xenetic Biosciences’s Moving Average
Xenetic Biosciences’s worth is way under its 50-day moving average of $1.64 and way below its 200-day moving average of $2.19.
More news about Xenetic Biosciences.
7. Amicus Therapeutics (FOLD) – Premarket: 4.41%
NASDAQ ended the session with Amicus Therapeutics falling 0.13% to $7.48 on Tuesday, following the last session’s downward trend. NASDAQ fell 1.2% to $11,662.79, following the last session’s downward trend on what was an all-around negative trend exchanging session today.
Volume
Today’s last reported volume for Amicus Therapeutics is 2100100, 45.24% below its average volume of 3835520.
Amicus Therapeutics’s last close was $7.48, 40.78% below its 52-week high of $12.63.
Amicus Therapeutics’s Sales
Amicus Therapeutics’s sales growth is 20.1% for the present quarter and 34.5% for the next. The company’s growth estimates for the current quarter and the next is 44.4% and 56%, respectively.
Amicus Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 18%, now sitting on 293.93M for the twelve trailing months.
Volatility
Amicus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.85%, a negative 1.17%, and a positive 3.51%, respectively.
Amicus Therapeutics’s highest amplitude of average volatility was 6.62% (last week), 4.22% (last month), and 3.51% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Amicus Therapeutics’s stock is considered to be oversold (<=20).
Amicus Therapeutics’s Stock Yearly Top and Bottom Value
Amicus Therapeutics’s stock is valued at $7.48 at 08:34 EST, way below its 52-week high of $12.63 and way higher than its 52-week low of $5.91.
Amicus Therapeutics’s Moving Average
Amicus Therapeutics’s worth is way under its 50-day moving average of $8.37 and way below its 200-day moving average of $10.00.
More news about Amicus Therapeutics.
8. Match Group (MTCH) – Premarket: 4.29%
NASDAQ ended the session with Match Group dropping 2.27% to $75.75 on Tuesday, after three successive sessions in a row of losses. NASDAQ fell 1.2% to $11,662.79, following the last session’s downward trend on what was an all-around down trend trading session today.
Volume
Today’s last reported volume for Match Group is 1859130, 48.11% below its average volume of 3583090.
Match Group’s last close was $75.75, 58.38% below its 52-week high of $182.00.
Match Group’s Sales
Match Group’s sales growth is 25.6% for the ongoing quarter and 28.8% for the next. The company’s growth estimates for the current quarter is 12.5% and a drop 1.8% for the next.
Match Group’s Revenue
Year-on-year quarterly revenue growth grew by 25.3%, now sitting on 2.83B for the twelve trailing months.
Volatility
Match Group’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.15%, a negative 1.10%, and a positive 3.74%, respectively.
Match Group’s highest amplitude of average volatility was 3.27% (last week), 4.26% (last month), and 3.74% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Match Group’s stock is considered to be oversold (<=20).
Match Group’s Stock Yearly Top and Bottom Value
Match Group’s stock is valued at $75.75 at 08:34 EST, way under its 52-week high of $182.00 and way above its 52-week low of $67.87.
Match Group’s Moving Average
Match Group’s value is way under its 50-day moving average of $91.49 and way below its 200-day moving average of $126.19.
More news about Match Group.
9. Trip.com (TCOM) – Premarket: 4.19%
NASDAQ ended the session with Trip.com rising 0.45% to $20.98 on Tuesday while NASDAQ dropped 1.2% to $11,662.79.
Volume
Today’s last reported volume for Trip.com is 3321600, 49.32% below its average volume of 6554450.
Trip.com’s last close was $20.98, 50.1% under its 52-week high of $42.04.
Trip.com’s Revenue
Year-on-year quarterly revenue growth declined by 2.2%, now sitting on 20.31B for the twelve trailing months.
Volatility
Trip.com’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.98%, a negative 0.17%, and a positive 4.35%, respectively.
Trip.com’s highest amplitude of average volatility was 3.53% (last week), 2.97% (last month), and 4.35% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Trip.com’s stock is considered to be oversold (<=20).
Trip.com’s Stock Yearly Top and Bottom Value
Trip.com’s stock is valued at $20.98 at 08:34 EST, way below its 52-week high of $42.04 and way higher than its 52-week low of $14.29.
Trip.com’s Moving Average
Trip.com’s value is way below its 50-day moving average of $23.51 and way below its 200-day moving average of $26.68.
More news about Trip.com.
10. NortonLifeLock (NLOK) – Premarket: 4.01%
NASDAQ ended the session with NortonLifeLock sliding 0.06% to $23.93 on Tuesday while NASDAQ dropped 1.2% to $11,662.79.
Volume
Today’s last reported volume for NortonLifeLock is 6319250, 10.14% above its average volume of 5736960.
NortonLifeLock’s last close was $23.93, 22.61% under its 52-week high of $30.92.
The company’s growth estimates for the current quarter and the next is 13.2% and 10%, respectively.
NortonLifeLock’s Revenue
Year-on-year quarterly revenue growth grew by 9.9%, now sitting on 2.75B for the twelve trailing months.
Volatility
NortonLifeLock’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.68%, a negative 0.63%, and a positive 2.02%, respectively.
NortonLifeLock’s highest amplitude of average volatility was 1.27% (last week), 1.50% (last month), and 2.02% (last quarter), respectively.
NortonLifeLock’s Stock Yearly Top and Bottom Value
NortonLifeLock’s stock is valued at $23.93 at 08:34 EST, way below its 52-week high of $30.92 and higher than its 52-week low of $23.47.
NortonLifeLock’s Moving Average
NortonLifeLock’s value is under its 50-day moving average of $26.55 and under its 200-day moving average of $26.18.
More news about NortonLifeLock.
Most Active Premarket Losers Today
1. HDFC Bank Limited (HDB) – Premarket: -3.11%
NYSE ended the session with HDFC Bank Limited sliding 0.23% to $53.00 on Tuesday while NYSE jumped 0.02% to $15,259.82.
Volume
Today’s last reported volume for HDFC Bank Limited is 982162, 59.97% below its average volume of 2453940.
HDFC Bank Limited’s last close was $53.00, 37.43% under its 52-week high of $84.70.
The company’s growth estimates for the present quarter and the next is 14.5% and 14.1%, respectively.
HDFC Bank Limited’s Revenue
Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 837.24B for the twelve trailing months.
Volatility
HDFC Bank Limited’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.41%, a negative 0.56%, and a positive 2.21%, respectively.
HDFC Bank Limited’s highest amplitude of average volatility was 0.78% (last week), 1.91% (last month), and 2.21% (last quarter), respectively.
HDFC Bank Limited’s Stock Yearly Top and Bottom Value
HDFC Bank Limited’s stock is valued at $53.00 at 08:34 EST, way under its 52-week low of $65.02.
HDFC Bank Limited’s Moving Average
HDFC Bank Limited’s worth is way under its 50-day moving average of $71.60 and way below its 200-day moving average of $73.80.
More news about HDFC Bank Limited.
2. Mizuho Financial Group (MFG) – Premarket: -0.87%
NYSE ended the session with Mizuho Financial Group dropping 2.97% to $2.29 on Tuesday, after four consecutive sessions in a row of losses. NYSE rose 0.02% to $15,259.82, after three sequential sessions in a row of gains, on what was a somewhat up trend trading session today.
Volume
Today’s last reported volume for Mizuho Financial Group is 1359760, 16.79% above its average volume of 1164230.
Mizuho Financial Group’s last close was $2.29, 28.66% under its 52-week high of $3.21.
Mizuho Financial Group’s Revenue
Year-on-year quarterly revenue growth grew by 12.1%, now sitting on 2.45T for the twelve trailing months.
Volatility
Mizuho Financial Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.29%, a negative 0.29%, and a positive 1.47%, respectively.
Mizuho Financial Group’s highest amplitude of average volatility was 1.44% (last week), 1.31% (last month), and 1.47% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Mizuho Financial Group’s stock is considered to be oversold (<=20).
Mizuho Financial Group’s Stock Yearly Top and Bottom Value
Mizuho Financial Group’s stock is valued at $2.29 at 08:34 EST, below its 52-week low of $2.33.
Mizuho Financial Group’s Moving Average
Mizuho Financial Group’s value is way below its 50-day moving average of $2.66 and way under its 200-day moving average of $2.88.
More news about Mizuho Financial Group.
3. TJX Companies (TJX) – Premarket: -0.21%
NYSE ended the session with TJX Companies falling 1.88% to $56.12 on Tuesday, after four sequential sessions in a row of losses. NYSE rose 0.02% to $15,259.82, after three successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.
Volume
Today’s last reported volume for TJX Companies is 5496820, 29.62% below its average volume of 7810250.
TJX Companies’s last close was $56.12, 27.06% under its 52-week high of $76.94.
The company’s growth estimates for the current quarter and the next is 14.1% and 82%, respectively.
TJX Companies’s Revenue
Year-on-year quarterly revenue growth grew by 128.8%, now sitting on 37.81B for the twelve trailing months.
Volatility
TJX Companies’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.59%, a negative 0.51%, and a positive 2.00%, respectively.
TJX Companies’s highest amplitude of average volatility was 2.06% (last week), 2.44% (last month), and 2.00% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
TJX Companies’s stock is considered to be oversold (<=20).
TJX Companies’s Stock Yearly Top and Bottom Value
TJX Companies’s stock is valued at $56.12 at 08:34 EST, under its 52-week low of $61.15.
TJX Companies’s Moving Average
TJX Companies’s worth is way below its 50-day moving average of $68.15 and way below its 200-day moving average of $68.50.
More news about TJX Companies.
4. America Movil (AMOV) – Premarket: -0.1%
NASDAQ ended the session with America Movil rising 0.89% to $19.29 on Tuesday, following the last session’s upward trend. NASDAQ dropped 1.2% to $11,662.79, following the last session’s downward trend on what was an all-around down trend trading session today.
Volume
Today’s last reported volume for America Movil is 473, 91.14% below its average volume of 5340.
America Movil’s last close was $18.83, 15.9% below its 52-week high of $22.39.
America Movil’s Revenue
Year-on-year quarterly revenue growth declined by 2.6%, now sitting on 1.01T for the twelve trailing months.
America Movil’s Stock Yearly Top and Bottom Value
America Movil’s stock is valued at $19.29 at 08:34 EST, way under its 52-week high of $22.39 and way higher than its 52-week low of $13.70.
America Movil’s Moving Average
America Movil’s value is under its 50-day moving average of $20.08 and above its 200-day moving average of $18.73.
More news about America Movil.
5. Mid (MAA) – Premarket: -0.08%
NYSE ended the session with Mid dropping 1.49% to $177.09 on Tuesday while NYSE rose 0.02% to $15,259.82.
Volume
Today’s last reported volume for Mid is 399902, 42.71% below its average volume of 698110.
Mid’s last close was $177.09, 19.1% below its 52-week high of $218.89.
Mid’s Sales
Mid’s sales growth is 4.8% for the current quarter and 5.7% for the next. The company’s growth estimates for the present quarter is 23.1% and a drop 2.8% for the next.
Mid’s Revenue
Year-on-year quarterly revenue growth grew by 5.8%, now sitting on 1.71B for the twelve trailing months.
Volatility
Mid’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.10%, a negative 0.72%, and a positive 1.41%, respectively.
Mid’s highest amplitude of average volatility was 1.10% (last week), 1.74% (last month), and 1.41% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Mid’s stock is considered to be oversold (<=20).
Mid’s Stock Yearly Top and Bottom Value
Mid’s stock is valued at $177.09 at 08:34 EST, way under its 52-week high of $218.89 and way higher than its 52-week low of $120.50.
Mid’s Moving Average
Mid’s value is way under its 50-day moving average of $202.72 and under its 200-day moving average of $178.07.
More news about Mid.
6. Genworth Financial (GNW) – Premarket: 0%
NYSE ended the session with Genworth Financial dropping 0% to $3.94 on Tuesday while NYSE rose 0.02% to $15,259.82.
Volume
Today’s last reported volume for Genworth Financial is 2148280, 46.52% below its average volume of 4017280.
Genworth Financial’s last close was $3.70, 19.74% below its 52-week high of $4.61.
Genworth Financial’s Revenue
Year-on-year quarterly revenue growth declined by 10.7%, now sitting on 8.62B for the twelve trailing months.
Genworth Financial’s Stock Yearly Top and Bottom Value
Genworth Financial’s stock is valued at $3.94 at 08:34 EST, way below its 52-week high of $4.61 and way higher than its 52-week low of $3.23.
Genworth Financial’s Moving Average
Genworth Financial’s value is higher than its 50-day moving average of $3.80 and higher than its 200-day moving average of $3.94.
More news about Genworth Financial.
7. Fox Corporation (FOX) – Premarket: 0%
NASDAQ ended the session with Fox Corporation sliding 0.42% to $31.11 on Tuesday while NASDAQ slid 1.2% to $11,662.79.
Volume
Today’s last reported volume for Fox Corporation is 628597, 40.45% below its average volume of 1055630.
Fox Corporation’s last close was $31.11, 23.96% below its 52-week high of $40.91.
Fox Corporation’s Sales
Fox Corporation’s sales growth is 5.7% for the ongoing quarter and 5.5% for the next. The company’s growth estimates for the current quarter is a negative 9.3% and positive 55.6% for the next.
Fox Corporation’s Revenue
Year-on-year quarterly revenue growth grew by 12.1%, now sitting on 13.24B for the twelve trailing months.
Volatility
Fox Corporation’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.24%, a negative 0.62%, and a positive 1.39%, respectively.
Fox Corporation’s highest amplitude of average volatility was 1.41% (last week), 1.69% (last month), and 1.39% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Fox Corporation’s stock is considered to be oversold (<=20).
Fox Corporation’s Stock Yearly Top and Bottom Value
Fox Corporation’s stock is valued at $31.11 at 08:34 EST, way under its 52-week high of $40.91 and above its 52-week low of $28.96.
Fox Corporation’s Moving Average
Fox Corporation’s value is way under its 50-day moving average of $35.49 and way under its 200-day moving average of $35.95.
More news about Fox Corporation.
8. Identiv (INVE) – Premarket: 0%
NASDAQ ended the session with Identiv falling 2.29% to $11.52 on Tuesday while NASDAQ fell 1.2% to $11,662.79.
Volume
Today’s last reported volume for Identiv is 57398, 72.13% below its average volume of 205953.
Identiv’s last close was $11.52, 60.28% under its 52-week high of $29.00.
Identiv’s Revenue
Year-on-year quarterly revenue growth grew by 17%, now sitting on 100.09M for the twelve trailing months.
Volatility
Identiv’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.59%, a negative 0.84%, and a positive 3.20%, respectively.
Identiv’s highest amplitude of average volatility was 1.63% (last week), 2.06% (last month), and 3.20% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Identiv’s stock is considered to be overbought (>=80).
Identiv’s Stock Yearly Top and Bottom Value
Identiv’s stock is valued at $11.52 at 08:34 EST, way below its 52-week high of $29.00 and above its 52-week low of $11.11.
Identiv’s Moving Average
Identiv’s worth is way below its 50-day moving average of $14.22 and way under its 200-day moving average of $18.83.
More news about Identiv.
9. Arcturus Therapeutics (ARCT) – Premarket: 0%
NASDAQ ended the session with Arcturus Therapeutics falling 0.82% to $16.84 on Tuesday, after two consecutive sessions in a row of losses. NASDAQ fell 1.2% to $11,662.79, following the last session’s downward trend on what was an all-around down trend exchanging session today.
Volume
Today’s last reported volume for Arcturus Therapeutics is 421229, 35.48% below its average volume of 652868.
Arcturus Therapeutics’s last close was $16.84, 74.09% under its 52-week high of $65.00.
Arcturus Therapeutics’s Sales
Arcturus Therapeutics’s sales growth is 607.3% for the ongoing quarter and 2092.3% for the next. The company’s growth estimates for the ongoing quarter is a negative 34.4% and positive 95.8% for the next.
Arcturus Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 8.8M for the twelve trailing months.
Volatility
Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.19%, a negative 2.48%, and a positive 6.34%, respectively.
Arcturus Therapeutics’s highest amplitude of average volatility was 15.94% (last week), 7.75% (last month), and 6.34% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Arcturus Therapeutics’s stock is considered to be oversold (<=20).
Arcturus Therapeutics’s Stock Yearly Top and Bottom Value
Arcturus Therapeutics’s stock is valued at $16.84 at 08:34 EST, way below its 52-week high of $65.00 and way above its 52-week low of $12.12.
Arcturus Therapeutics’s Moving Average
Arcturus Therapeutics’s worth is way below its 50-day moving average of $22.97 and way below its 200-day moving average of $35.56.
More news about Arcturus Therapeutics.
10. Vanguard Short-Term (VGSH) – Premarket: 0.02%
NASDAQ ended the session with Vanguard Short-Term jumping 0.05% to $59.15 on Tuesday, after five successive sessions in a row of losses. NASDAQ fell 1.2% to $11,662.79, following the last session’s downward trend on what was an all-around negative trend exchanging session today.
Volume
Today’s last reported volume for Vanguard Short-Term is 2547310, 20.35% below its average volume of 3198260.
More news about Vanguard Short-Term.
Stay up to date with our premarket winners and losers daily report
